Modesto DʼAprile

514 total citations
34 papers, 399 citations indexed

About

Modesto DʼAprile is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Modesto DʼAprile has authored 34 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Modesto DʼAprile's work include Lung Cancer Research Studies (14 papers), Cancer Treatment and Pharmacology (8 papers) and Cancer therapeutics and mechanisms (8 papers). Modesto DʼAprile is often cited by papers focused on Lung Cancer Research Studies (14 papers), Cancer Treatment and Pharmacology (8 papers) and Cancer therapeutics and mechanisms (8 papers). Modesto DʼAprile collaborates with scholars based in Italy, United States and Czechia. Modesto DʼAprile's co-authors include Antônio Rossi, Ciro Gallo, Filippo de Marinis, S. Monfardini, S. Cigolari, Giovanni Pietro Ianniello, Franco Perrone, Cesare Gridelli, Andrea Bianco and Francesco Di Costanzo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Modesto DʼAprile

31 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Modesto DʼAprile Italy 12 272 136 89 89 85 34 399
Leo J. Ostruszka United States 7 209 0.8× 191 1.4× 130 1.5× 44 0.5× 44 0.5× 7 388
Aparna Pallavajjala United States 12 138 0.5× 80 0.6× 136 1.5× 109 1.2× 68 0.8× 32 373
Kajsa Ericson Lindquist Sweden 9 222 0.8× 128 0.9× 148 1.7× 102 1.1× 43 0.5× 12 393
Seiichi Fukuyama Japan 12 190 0.7× 186 1.4× 76 0.9× 65 0.7× 45 0.5× 26 422
Ana B. Galván Spain 9 112 0.4× 138 1.0× 81 0.9× 75 0.8× 27 0.3× 13 307
S. Smith United States 3 345 1.3× 161 1.2× 242 2.7× 90 1.0× 31 0.4× 5 506
Marcella Marconi Italy 13 401 1.5× 185 1.4× 76 0.9× 152 1.7× 50 0.6× 15 526
J.-O. Bay France 10 138 0.5× 82 0.6× 78 0.9× 40 0.4× 36 0.4× 24 370
Omar Kayaleh United States 8 301 1.1× 109 0.8× 162 1.8× 73 0.8× 63 0.7× 15 457
H Nishii Japan 9 138 0.5× 83 0.6× 175 2.0× 97 1.1× 45 0.5× 15 490

Countries citing papers authored by Modesto DʼAprile

Since Specialization
Citations

This map shows the geographic impact of Modesto DʼAprile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Modesto DʼAprile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Modesto DʼAprile more than expected).

Fields of papers citing papers by Modesto DʼAprile

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Modesto DʼAprile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Modesto DʼAprile. The network helps show where Modesto DʼAprile may publish in the future.

Co-authorship network of co-authors of Modesto DʼAprile

This figure shows the co-authorship network connecting the top 25 collaborators of Modesto DʼAprile. A scholar is included among the top collaborators of Modesto DʼAprile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Modesto DʼAprile. Modesto DʼAprile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Placido, Sabino De, Michelino De Laurentiis, M. De Lena, et al.. (2005). A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. British Journal of Cancer. 92(3). 467–474. 24 indexed citations
3.
Silvestris, Nicola, Modesto DʼAprile, Giovanna Andreola, et al.. (2004). Rationale for the use of gemcitabine in breast cancer (Review). International Journal of Oncology. 24(2). 389–98. 11 indexed citations
4.
Piga, A., Rolando Nortilli, Gian Luigi Cetto, et al.. (2004). Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site. British Journal of Cancer. 90(10). 1898–1904. 19 indexed citations
5.
Cosimo, Serena Di, et al.. (2002). Gastric Stump Lymphoma Five Years After Distal Gastrectomy. Leukemia & lymphoma. 44(2). 365–367. 4 indexed citations
6.
Marinis, Filippo de, Monica Rinaldi, Andrea Ardizzoni, et al.. (1999). The Role of Vindesine and Lonidamine in the Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer: A Phase III Randomized Fonicap Trial. Tumori Journal. 85(3). 177–182. 29 indexed citations
7.
Arcangeli, Giorgio, L. D’Angelo, Giuseppe Giovinazzo, et al.. (1998). Conservative surgery and radiotherapy in early stage breast cancer: a comparison between tumourectomy and quadrantectomy. Radiotherapy and Oncology. 46(1). 39–45. 8 indexed citations
8.
Gridelli, Cesare, Francesco Perrone, Giovanni Pietro Ianniello, et al.. (1998). Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-Isole.. Journal of Clinical Oncology. 16(4). 1414–1419. 22 indexed citations
9.
Bajetta, Emilio, Nicoletta Zilembo, Sandro Barni, et al.. (1997). A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: Endocrine and clinical results. Annals of Oncology. 8(7). 649–654. 11 indexed citations
10.
Gridelli, Cesare, Franco Perrone, Ciro Gallo, et al.. (1997). Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study. European Journal of Cancer. 33(3). 392–397. 77 indexed citations
11.
Gridelli, Cesare, S. Palmeri, Modesto DʼAprile, et al.. (1996). Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. Annals of Oncology. 7(8). 821–826. 32 indexed citations
12.
Gridelli, Cesare, Modesto DʼAprile, S. Palmeri, et al.. (1996). Phase I Study of Chemotherapy with Carboplatin, Epirubicin, and Escalating Dose of VP-16 with G-CSF Support in Extensive Small Cell Lung Cancer. American Journal of Clinical Oncology. 19(6). 589–591. 1 indexed citations
13.
Leo, Angelo Di, Emilio Bajetta, Roberto Buzzoni, et al.. (1995). Epirubicin Plus Medroxyprogesterone as Second-Line Treatment of Advanced Prostatic Cancer. American Journal of Clinical Oncology. 18(3). 239–244. 4 indexed citations
14.
Garaci, Enrico, M López, G Bonsignore, et al.. (1995). Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-αl and interferon-α2a. European Journal of Cancer. 31(13-14). 2403–2405. 36 indexed citations
15.
Angelini, Francesco, G. Arcangeli, R Tersigni, et al.. (1995). A Pilot Study of Concomitant Protracted Venous Infusion 5-Fluorouracil and Hyperfractionated Radiotherapy in Rectal Tumors. American Journal of Clinical Oncology. 18(5). 369–375. 2 indexed citations
16.
Zilembo, Nicoletta, Emilio Bajetta, Cristina Noberasco, et al.. (1995). HORMONAL-THERAPY IN PATIENTS WITH STAGE-IV BREAST-CANCER AT DIAGNOSIS. Oncology Reports. 2(4). 601–602. 1 indexed citations
17.
Gridelli, Cesare, Modesto DʼAprile, Carlo Curcio, et al.. (1994). Carboplatin plus epirubicin plus VP-16, concurrent ‘split course’ radiotherapy and adjuvant surgery for limited small cell lung cancer. Lung Cancer. 11(1-2). 83–91. 7 indexed citations
18.
Gridelli, Cesare, Modesto DʼAprile, S. Palmeri, et al.. (1994). Phase I–II study of carboplatin, epirubicin and VP-16 plus G-CSF in extensive small cell lung cancer (SCLC). Lung Cancer. 11. 99–99. 4 indexed citations
19.
Bartolomeo, Maria Di, Emilio Bajetta, Nicoletta Zilembo, et al.. (1993). Treatment of Carcinoid Syndrome with Recombinant Interferon Alpha-2a. Acta Oncologica. 32(2). 235–238. 34 indexed citations
20.
D’Aiuto, Giuseppe, Silvana Del Vecchio, Luigi Mansi, et al.. (1991). Malignant Melanoma of the Nipple: A Case Studied with Radiolabeled Monoclonal Antibody. Tumori Journal. 77(5). 449–451. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leo J. Ostruszka Breakdown of academic impact, for papers by Aparna Pallavajjala Breakdown of academic impact, for papers by Kajsa Ericson Lindquist Breakdown of academic impact, for papers by Seiichi Fukuyama Breakdown of academic impact, for papers by Ana B. Galván Breakdown of academic impact, for papers by S. Smith Breakdown of academic impact, for papers by Marcella Marconi Breakdown of academic impact, for papers by J.-O. Bay Breakdown of academic impact, for papers by Omar Kayaleh Breakdown of academic impact, for papers by H Nishii
Rankless by CCL
2026